InayofuataMwongozo unaofuata
AI Target Identification in Drug Discovery
Viwanda
MWONGOZO wa Viwanda
AI methods can support several stages of drug research, including protein-structure prediction, molecular property prediction, virtual screening and molecule generation.
Sikiliza mwongozo huuInaonyeshwa na AI · ~2 min
A model result is a research hypothesis or prioritization signal, not evidence of clinical safety or efficacy.
AlphaFold predicts protein structures, while AlphaFold 3 extends structure prediction to biomolecular complexes involving proteins, nucleic acids, small molecules and other components. MoleculeNet describes machine-learning tasks over molecular representations including graphs and SMILES. Deep Docking illustrates one virtual-screening approach that uses predictions to reduce how many compounds require expensive docking calculations. DeepTox and later molecular-generation studies address toxicity prediction and candidate generation; these methods do not establish a compound’s safety, efficacy or clinical success. FDA describes preclinical testing and an IND process before clinical studies in people.
Using AlphaFold to predict protein structures, as reported in its paper and resource database.
Using AlphaFold 3 to predict structures and interactions among proteins, nucleic acids, small molecules and other biomolecules.
Representing molecules as graphs or SMILES strings in molecular-learning benchmarks.
Using virtual screening to prioritize compounds for experimental testing, with predictions treated as uncertain.
Evaluate screening and generation methods on prospective, target-relevant data and report experimental confirmation rates. Follow regulatory requirements for preclinical and human research; remove candidates only after evidence appropriate to the task, rather than treating model scores as final decisions.
Jarida halali
Hadithi tatu za AI zilizothibitishwa kila asubuhi ya wiki, zimetengenezwa kwa Kiingereza rahisi. Bila malipo daima, hakuna matangazo.
Barua pepe moja kila siku ya wiki. Jiondoe kwa bonyeza moja. Hatutauza au kushiriki anwani yako.
Jijaribu mwenyewe
Maoni ya haraka juu ya kila jibu, na cheti kinachoweza kushirikishwa na kitambulisho kinachoweza kuthibitishwa baada ya kupita kozi.
Changia elimu ya AI bila malipo. AI Understanding ni 501(c)(3) isiyo na faida — hakuna matangazo, hakuna kizuizi cha malipo, daima. Toa mchango
AI methods can support several stages of drug research, including protein-structure prediction, molecular property prediction, virtual screening and molecule generation. A model result is a research hypothesis or prioritization signal, not evidence of clinical safety or efficacy.
AlphaFold ilitumia mafunzo ya kina kutabiri miundo ya 3D ya protini kwa kiwango, ikiwapa watafiti miundo ya miundo ambayo hapo awali ilichukua miaka ya majaribio.
Molekuli kwa kawaida ni grafu (atomi = nodi, bondi = kingo) zinazochakatwa na mitandao ya neural ya grafu, au kusimba kama mifuatano ya SMILES kwa miundo ya mfuatano.
Uchunguzi pepe hutumia miundo kupata alama za maktaba kubwa za molekuli katika siliko, kwa hivyo ni watahiniwa wakuu pekee ndio hutengenezwa na kujaribiwa kwenye maabara.
Computational ADME/toxicity predictions can prioritize compounds for follow-up; they are model outputs and do not establish safety or replace experimental testing.
Miundo ya uzalishaji kama vile VAE na miundo ya uenezaji sampuli ya miundo mipya kutoka nafasi iliyofunzwa ya kemikali, ikiboresha sifa zinazohitajika.
Endelea kujifunza
Miongozo zaidi imechaguliwa kwa mada hii
InayofuataMwongozo unaofuata
AI Target Identification in Drug Discovery
Viwanda